Nucleophosmin Interacts with and Inhibits the Catalytic Function of Eukaryotic Initiation Factor 2 Kinase PKR

Qishen Pang, Tracy A. Christianson, Tara Koretsky, Hanqian Carlson, Larry David, Winifred Keeble, Gregory R. Faulkner, Ashley Speckhart, Grover C. Bagby

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

In normal cells the protein kinase PKR effects apoptosis in response to various extra and intracellular cues and can also function to suppress the neoplastic phenotype. Because most neoplastic cells are resistant to certain apoptotic cues, we reasoned that an early molecular event in carcinogenesis or leukemogenesis might be the inactivation of PKR by expression or activation of intracellular PKR inhibitors. Seeking novel PKR-modulating proteins we report here that nucleophosmin (NPM), a protein frequently overexpressed in a variety of human malignancies, binds to PKR, and inhibits its activation. Co-immunoprecipitation and in vitro binding experiments showed that NPM associated with PKR. Kinase assays demonstrated that recombinant NPM inhibited PKR activation in a dose-dependent manner. In addition, purified recombinant NPM was phosphorylated by activated PKR. Most importantly, overexpression of NPM suppressed PKR activity, enhanced protein synthesis, and inhibited apoptosis. Lymphoblasts from patients with Fanconi anemia (FA) expressed low levels of NPM, which correlated with high ground-state activation of PKR and cellular hypersensitivity to apoptotic cues, but enforced expression of NPM in these mutant cells reduced aberrant apoptotic responses. Inhibition of PKR by NPM may be one mechanism by which neoplastic clones evolve in sporadic malignancies and in neoplastic cells arising in the context of the cancer pre-disposition syndrome, Fanconi anemia.

Original languageEnglish (US)
Pages (from-to)41709-41717
Number of pages9
JournalJournal of Biological Chemistry
Volume278
Issue number43
DOIs
StatePublished - Oct 24 2003

Fingerprint

Eukaryotic Initiation Factor-2
Phosphotransferases
Chemical activation
Cues
Fanconi Anemia
eIF-2 Kinase
Apoptosis
Neoplasms
Proteins
nucleophosmin
Immunoprecipitation
Ground state
Assays
Hypersensitivity
Carcinogenesis
Clone Cells
Phenotype

ASJC Scopus subject areas

  • Biochemistry

Cite this

Nucleophosmin Interacts with and Inhibits the Catalytic Function of Eukaryotic Initiation Factor 2 Kinase PKR. / Pang, Qishen; Christianson, Tracy A.; Koretsky, Tara; Carlson, Hanqian; David, Larry; Keeble, Winifred; Faulkner, Gregory R.; Speckhart, Ashley; Bagby, Grover C.

In: Journal of Biological Chemistry, Vol. 278, No. 43, 24.10.2003, p. 41709-41717.

Research output: Contribution to journalArticle

Pang, Q, Christianson, TA, Koretsky, T, Carlson, H, David, L, Keeble, W, Faulkner, GR, Speckhart, A & Bagby, GC 2003, 'Nucleophosmin Interacts with and Inhibits the Catalytic Function of Eukaryotic Initiation Factor 2 Kinase PKR', Journal of Biological Chemistry, vol. 278, no. 43, pp. 41709-41717. https://doi.org/10.1074/jbc.M301392200
Pang, Qishen ; Christianson, Tracy A. ; Koretsky, Tara ; Carlson, Hanqian ; David, Larry ; Keeble, Winifred ; Faulkner, Gregory R. ; Speckhart, Ashley ; Bagby, Grover C. / Nucleophosmin Interacts with and Inhibits the Catalytic Function of Eukaryotic Initiation Factor 2 Kinase PKR. In: Journal of Biological Chemistry. 2003 ; Vol. 278, No. 43. pp. 41709-41717.
@article{d46ed967b5ca4b7b91ba0ff338b8ebb6,
title = "Nucleophosmin Interacts with and Inhibits the Catalytic Function of Eukaryotic Initiation Factor 2 Kinase PKR",
abstract = "In normal cells the protein kinase PKR effects apoptosis in response to various extra and intracellular cues and can also function to suppress the neoplastic phenotype. Because most neoplastic cells are resistant to certain apoptotic cues, we reasoned that an early molecular event in carcinogenesis or leukemogenesis might be the inactivation of PKR by expression or activation of intracellular PKR inhibitors. Seeking novel PKR-modulating proteins we report here that nucleophosmin (NPM), a protein frequently overexpressed in a variety of human malignancies, binds to PKR, and inhibits its activation. Co-immunoprecipitation and in vitro binding experiments showed that NPM associated with PKR. Kinase assays demonstrated that recombinant NPM inhibited PKR activation in a dose-dependent manner. In addition, purified recombinant NPM was phosphorylated by activated PKR. Most importantly, overexpression of NPM suppressed PKR activity, enhanced protein synthesis, and inhibited apoptosis. Lymphoblasts from patients with Fanconi anemia (FA) expressed low levels of NPM, which correlated with high ground-state activation of PKR and cellular hypersensitivity to apoptotic cues, but enforced expression of NPM in these mutant cells reduced aberrant apoptotic responses. Inhibition of PKR by NPM may be one mechanism by which neoplastic clones evolve in sporadic malignancies and in neoplastic cells arising in the context of the cancer pre-disposition syndrome, Fanconi anemia.",
author = "Qishen Pang and Christianson, {Tracy A.} and Tara Koretsky and Hanqian Carlson and Larry David and Winifred Keeble and Faulkner, {Gregory R.} and Ashley Speckhart and Bagby, {Grover C.}",
year = "2003",
month = "10",
day = "24",
doi = "10.1074/jbc.M301392200",
language = "English (US)",
volume = "278",
pages = "41709--41717",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "43",

}

TY - JOUR

T1 - Nucleophosmin Interacts with and Inhibits the Catalytic Function of Eukaryotic Initiation Factor 2 Kinase PKR

AU - Pang, Qishen

AU - Christianson, Tracy A.

AU - Koretsky, Tara

AU - Carlson, Hanqian

AU - David, Larry

AU - Keeble, Winifred

AU - Faulkner, Gregory R.

AU - Speckhart, Ashley

AU - Bagby, Grover C.

PY - 2003/10/24

Y1 - 2003/10/24

N2 - In normal cells the protein kinase PKR effects apoptosis in response to various extra and intracellular cues and can also function to suppress the neoplastic phenotype. Because most neoplastic cells are resistant to certain apoptotic cues, we reasoned that an early molecular event in carcinogenesis or leukemogenesis might be the inactivation of PKR by expression or activation of intracellular PKR inhibitors. Seeking novel PKR-modulating proteins we report here that nucleophosmin (NPM), a protein frequently overexpressed in a variety of human malignancies, binds to PKR, and inhibits its activation. Co-immunoprecipitation and in vitro binding experiments showed that NPM associated with PKR. Kinase assays demonstrated that recombinant NPM inhibited PKR activation in a dose-dependent manner. In addition, purified recombinant NPM was phosphorylated by activated PKR. Most importantly, overexpression of NPM suppressed PKR activity, enhanced protein synthesis, and inhibited apoptosis. Lymphoblasts from patients with Fanconi anemia (FA) expressed low levels of NPM, which correlated with high ground-state activation of PKR and cellular hypersensitivity to apoptotic cues, but enforced expression of NPM in these mutant cells reduced aberrant apoptotic responses. Inhibition of PKR by NPM may be one mechanism by which neoplastic clones evolve in sporadic malignancies and in neoplastic cells arising in the context of the cancer pre-disposition syndrome, Fanconi anemia.

AB - In normal cells the protein kinase PKR effects apoptosis in response to various extra and intracellular cues and can also function to suppress the neoplastic phenotype. Because most neoplastic cells are resistant to certain apoptotic cues, we reasoned that an early molecular event in carcinogenesis or leukemogenesis might be the inactivation of PKR by expression or activation of intracellular PKR inhibitors. Seeking novel PKR-modulating proteins we report here that nucleophosmin (NPM), a protein frequently overexpressed in a variety of human malignancies, binds to PKR, and inhibits its activation. Co-immunoprecipitation and in vitro binding experiments showed that NPM associated with PKR. Kinase assays demonstrated that recombinant NPM inhibited PKR activation in a dose-dependent manner. In addition, purified recombinant NPM was phosphorylated by activated PKR. Most importantly, overexpression of NPM suppressed PKR activity, enhanced protein synthesis, and inhibited apoptosis. Lymphoblasts from patients with Fanconi anemia (FA) expressed low levels of NPM, which correlated with high ground-state activation of PKR and cellular hypersensitivity to apoptotic cues, but enforced expression of NPM in these mutant cells reduced aberrant apoptotic responses. Inhibition of PKR by NPM may be one mechanism by which neoplastic clones evolve in sporadic malignancies and in neoplastic cells arising in the context of the cancer pre-disposition syndrome, Fanconi anemia.

UR - http://www.scopus.com/inward/record.url?scp=0142149184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142149184&partnerID=8YFLogxK

U2 - 10.1074/jbc.M301392200

DO - 10.1074/jbc.M301392200

M3 - Article

C2 - 12882984

AN - SCOPUS:0142149184

VL - 278

SP - 41709

EP - 41717

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 43

ER -